Affiliation:
1. Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China
Abstract
Abstract:
Due to their unique biological functionality, nanocarriers can be designed to deliver va-rious anti-tumor drugs in vivo, which has a wide and important application prospect in the field of tumor therapy. However, poor biosafety, short blood circulation time, and weak targeting ability still limit the application of nanoparticles in tumor therapy. In recent years, with the development of biomedicine, the biomimetic technology-based biomembrane-mediated drug delivery system is ex-pected to achieve a breakthrough in tumor-targeted therapy due to low immunogenicity, tumor tar-geting, the adjustability and versatility of intelligent nanocarrier design. This paper mainly reviews the research process of different types of the cell membrane (erythrocyte membrane, cancer cell membrane, bacterial membrane, stem cell membrane, and hybrid membrane)-camouflaged nanopar-ticles in tumor therapy, as well as the challenges and development prospects in clinical application.
Funder
Talent Project from Army Medical University
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献